Диссертация (1154900), страница 20
Текст из файла (страница 20)
—2013. — Vol.14. — P.2079-2085.82. Hysteroscopic morcellation: review of the manufacturer and user facility118device experience (MAUDE) database / Haber K., Hawkins E., Levie M. et al. // J.Minim. Invasive Gynecol. — 2015. — Vol.22. — P.110-114.83. Immunoexpression of Steroid Hormone Receptors and Proliferation Markersin Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Susscrofa / Mozzachio K., Moore A.B., Kissling G.E. et al. // Toxicol.
Pathol. — 2016. —Vol.44. — P. 450-457.84. Increased risk of breast cancer in women with uterine myoma: a nationwide,population-based, case-control study / Tseng Jenn-Jhy, Chen Yi-Huei, Chiang Hsiu-Yinet al. // J. Gynecol. Oncol. — 2017. — Vol.28. Р.28-3585. Individualized vaginal bleeding experience of women with uterine fibroids inthe PEARL I randomized controlled trial comparing the effects of ulipristal acetate orplacebo / Barlow D.H., Lumsden M.A., Fauser B.C.
[et all.] // Hum. Reprod. —2014. — Vol.29. — P.480-489.86. KwonY.S.Transient occlusion of uterinearteries inlaparoscopic uterine surgery /KwonY.S., Roh H.J., Ahn J.W. // JSLS. — 2015. —Vol.19. Р.189.87. Laparoscopic hysterectomy in case of uteri weighing ≥1 kilogram: a series of71 cases and review of the literature / Uccella S., Cromi A., Serati M., Casarin J. [et al.]/ J. Minim. Invasive Gynecol. — 2014. — Vol.21. — P.
460-465.88. Laparoscopic Morcellation of Fibroid and Uterus In-Bag / TrivediP.H., Patil S.S., Parekh N.A. [et al.] // J. Obstet. Gynaecol. India. — 2015. —Vol. 65. — P. 396-400.89. Laparoscopic myomectomy / Stoica R.A., Bistriceanu I., Sima R.et al. // J.Med. Life. — 2014. — Vol. 7. — P. 522-524.90. Lieng, M. Risk of morcellation of uterine leiomyosarcomas in laparoscopicsupracervical hysterectomy and laparoscopic myomectomy, a retrospective trialincluding 4791 women / Lieng M., Berner E., Busund B. // J.
Minim. Invasive.Gynecol. — 2015. — Vol.22. — P.410-414.91. Magakyan, S.G. Fattori medico e sociale in donne con hysteromyoma /S.G Magakyan, S.P. Sinchikhin, L.V. Stepanyan // Italian Science Review. — 2014. —119Vol. 3. — P. 131-133.92. Mara, M. Embolization of uterine fibroids from the point of view of thegynecologist: pros and cons / Mara M., Kubinova K. // International Journal ofWomen's Health. — 2014. — Vol.6. — Р.623-629.93. Metwally M. Surgical treatment of fibroids for subfertility / Metwally M.,Cheong Y.C., Horne A.W. // Cochrane Database Syst. Rev. — 2012. —Vol.14. – № 3 P.152-15594. Milad, M.P. Laparoscopic morcellator-related complications / Milad M.P.,Milad E.A.
// J. Minim. Invasive Gynecol. — 2014. — Vol. 21. — P.486-491.95. Minimally invasive surgical techniques versus open myomectomy for uterinefibroids / Bhave Ch.P., Franik S., Pouwer A.W., Farquhar C. // Cochrane Database Syst.Rev. — 2014. — Vol.21.- P.175-178.96. Moravek, MB. Endocrinology of uterine fibroids: steroid hormones, stemcells, and genetic contribution / Moravek M.B., Bulun S.E. // Curr. Opin. Obstet.Gynecol.
— 2015. — Vol. 27. — P. 276-283.97. MRI assessment of uterine artery patency and fibroid infarction rates 6months after uterine artery embolization with nonspherical polyvinyl alcohol / Das R.,Gonsalves M. [et al.] // Cardiovasc. Intervent. Radiol. — 2013. — Vol.36. — P. 12801287.98. Myomectomy by Robotically Assisted Laparoscopic Surgery: Results at FochHospital, Paris / Asmar J., Even M., Carbonnel M.
[et al.] // Front Surg. — 2015. —Vol.20. — Р.40-45.99. Oliva, E. Practical issues in uterine pathology from banal to bewildering: theremarkable spectrum of smooth muscle neoplasia / E. Oliva // Modern Pathology. —2016. —Vol.29. — P. 104-120.100. Options on fibroid morcellation: a literature review / Brölmann H.,Tanos V., Grimbizis G. [ et al.] // Gynecol. Surg. — 2015. — Vol. 12.
— P.3-15.101. Post-operative hemorrhage after myomectomy: safety and efficacy oftranscatheter uterine artery embolization / Wan A.Y., Shin J.H., Yoon H.K. [et al.]//Korean J. Radiol. — 2014. — Vol.15. — P. 356-363.120102. Potential of minimally invasive procedures in the treatment of uterinefibroids: a focus on magnetic resonance-guided focused ultrasound therapy /Fischer K., McDannold N.J., Tempany C.M. [et al.] // Int.
J. Womens Health. —2015. — Vol. 13. — P. 901–912.103. Practice patterns and postoperative complications before and after US Foodand Drug Administration safety communication on power morcellation / Harris J.A.,Swenson C.W., Uppal S. [et al.] // Am. J. Obstet. Gynecol. — 2016. — Vol. 214. - №2.– P.23-28.104. Proceedings from the Third National Institutes of Health InternationalCongress on Advances in Uterine Leiomyoma Research: comprehensive review,conference summary and future recommendations / Segars J.H., Parrott E.C., Nagel J.D.[et al.] // Hum.
Reprod. Update. — 2014. — Vol. 20. — P. 309-333.105. Recurrence factors and reproductive outcomes of laparoscopic myomectomyand minilaparotomic myomectomy for uterine leiomyomas / Dong Gi Shin, Heon JongYoo, Yeon Ah Lee [et al.] // Obstet. Gynecol. Sci. — 2017. — Vol. 60. — P. 193–199.106. Recurrence of uterine tissue residues after laparoscopic hysterectomy ormyomectomy / Cunjian Yi., Li Li., Xiaowen Wang et al.
// Pak. J. Med. Sci. — 2014.— Vol.30. — P. 1134–1136.107. Role of vitamin D in uterine fibroid biology / Brakta S., Diamond J.S., AlHendy A. [et al.] // Fertil. Steril. — 2015. — Vol.104. — P. 698-706.108. Savan, Shah. In Laparoscopic Myomectomy, Does a Caseload of 100Patients During the Learning Curve Produce a Significant Improvement in PerformanceMeasures? / Savan Shah, Jimi F. Odejinmi, Nilesh Agarwal. // J. Obstet.
Gynaecol.India. — 2016. — Vol. 66. — P. 422–427.109. Successful useof laparoscopic myomectomy toremoveagiant uterine myoma: a case report / Aksoy H., Aydin T., Özdamar Ö. [et al.] //J. Med.Case Rep. — 2015. — V. 9.- №17 — Р. 286.110. Survey among ESGE members on leiomyosarcoma morcellation incidence /Tanos Vasilios, Brölmann Hans, DeWilde Rudi Leon [et al.] // .Gynecol. Surg.
—2017. — Vol. 14. — P.25.121111. Szamatowicz, M. Selective progesterone receptor modulator (ulipristalacetate--a new option in the pharmacological treatment of uterine fibroids in women /Szamatowicz M, Kotarski J. // Ginekol. Pol. — 2013. — Vol.84. — P.
219-222.112. Technique for Vascular Control During Robotic-assisted LaparoscopicMyomectomy / Lindsay Clark Donat, Gulden Menderes, Amanda M. Tower, MasoudAzodiA // JSLS. — 2015. — Vol. 22. — P. 543.113. The Estimated Annual Cost of Uterine Leiomyomata in the United States /Cardozo ER., Clark AD., Banks NK. et al. Am. J.
Obstet. Gynecol. — 2012. —Vol.206. P.211-214114. The etiopathogenesis of uterine fibromatosis / Manta L., Suciu N.,Toader O. [et al.] // J. Med. Life. — 2016. — Vol.9. — P. 39–45.115. The fibroid as clinical problem / Calaf J., Arqué M., Porta O. et al. // Med.Clin. (Barc). — 2013. — Vol.141. — P.1-6.116. The management of uterine fibroids in women with otherwise unexplainedinfertility / Carranza-Mamane B., Havelock J., Hemmings R. [et al.] // J. Obstet.Gynaecol.
Can. — 2015. — Vol.37. — P.277-288.117. The management of uterine leiomyomas / Vilos G.A., Allaire C.,Laberge P.Y. [et al.] // J. Obstet. Gynaecol. Can. — 2015. — Vol.37. — P.157-181.118. TheSydneyContainedInBagMorcellationtechnique/McKenna J.B., Kanade T., Choi S. [et al.] // J. Minim. Invasive. Gynecol.
— 2014. —Vol. 21. — P.984-985.119. Thompson Mayra, J. Intramural myomas: to treat or not to treat / ThompsonMayra J., Carr Bruce R. // Int. J. Womens Health. — 2016. — Vol. 8. — P. 145–149.120. Ton, R. A medical-legal review of power morcellation in the face of therecent FDA warning and litigation / Ton R., Kilic G.S., Phelps J.Y. // J. Minim.Invasive Gynecol. — 2015. —Vol. 22. — P. 564-572.121.
Transvaginal morcellation / Clark Donat L., Clark M., Tower A.M. [et al.] //JSLS. — 2015. — Vol. 19. Р.255-261.122. Ultrasound-guided percutaneous microwave ablation for submucosal uterinefibroids // Yang Y., Zhang J., Han Z.Y. [et al.] // J. Minim. Invasive Gynecol. —1222014. — Vol.21. — P. 436-441.123.
Uterine artery embolization for severe symptomatic fibroids: effects onfertility and symptoms / Sirkeci F., Narang L., Naguib N. [et al.] // Hum. Reprod. —2014. — Vol.29. — P. 1832-1833.124. Uterinearteryembolizationforsymptomaticuterinefibroids/Gupta J.K., Sinha A., Lumsden M.A. et al. // Cochrane Database Syst Rev.— 2014. —Vol.26. Р.95-114.125.
Uterine artery embolization with spherical PVA-PVAc particles aspreparation for surgical resection of myomas / Ghiaroni J., Lopez G.E., CoutinhoJunior A.C. et al. // Rev. Col. Bras. Cir.— 2013. — Vol. 40. — P. 386-391.126. Uterine fibroids: clinical manifestations and contemporary management /Doherty L., Mutlu L., Sinclair D. et al. // Reprod.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
